secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2026-06-16T12:07:31+00:00
Accession:  0001628280-26-043419
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave cuts Q2 2026 revenue guidance to $8.5-9.5M on Ultramist market disruption
--------------------------------------------------------------------------------

- Revenue guidance for Q2 2026 reduced to $8.5-$9.5M from prior guidance provided on May 13.
- Downgrade driven by CMS reimbursement clawbacks causing wound care practice closures and cannibalization from used Ultramist systems.
- Applicator consumables on pace for record quarterly unit volume in Q2.
- CEO Morgan Frank sees positive applicator outlook but near-term headwinds from capital sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026043419/0001628280-26-043419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026043419/snwv-20260616.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-043419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer